Abiopharma

CENTRAL SECURITIES CORP (CET)

Symbol	CET
Name	CENTRAL SECURITIES CORP
Sector	FINANCE
Region	North America
Industry	Finance/Investors Services
Address	630 FIFTH AVENUE, NEW YORK, NY 10111
Telephone	212-698-2020
Fax	—
Email	—
Website	https://www.centralsecurities.com
Incorporation	UNDEFINED
Incorporated On	—
Employees	—
Fiscal Year	—
Public Since	—
Exchanges	NASDAQ
Auditor	—
Audit Status	NOT PROVIDED
Reporting Status	—
CIK	0000018748
Description	Primary investment objective is growth of capital. Income received from securities is a secondary consideration. Additional info from NASDAQ: Primary investment objective is growth of capital. Income received from securities is a secondary consideration.

2026-07-23 13:49

ENDEAVOR FOUNDATION, INC. 🔴 sold 30.8K shares of CENTRAL SECURITIES CORP (CETCET) Transaction Date: Jul 21, 2026 | Filing ID: 000046

2026-06-30 18:32

Director Hill John C 🟢 acquired 233 shares of CENTRAL SECURITIES CORP (CET) at $51.87 Transaction Date: Jun 26, 2026 | Filing ID: 000044

2026-06-30 16:21

Director Blackford Leo Price 🟢 acquired 204 shares of CENTRAL SECURITIES CORP (CET) at $52.38 Transaction Date: Jun 26, 2026 | Filing ID: 000042

2026-06-23 15:21

ENDEAVOR FOUNDATION, INC. 🔴 sold 38.2K shares of CENTRAL SECURITIES CORP (CET) Transaction Date: Jun 18, 2026 | Filing ID: 000039

2026-06-01 20:05

Central Securities Corporation Declares Dividend

2026-05-28 16:18

New Form NPORT-P - CENTRAL SECURITIES CORP Filed: 2026-05-28 AccNo: 0002071691-26-012547 Size: 113 KB

2026-05-21 13:31

ENDEAVOR FOUNDATION, INC. 🔴 sold 19.0K shares of CENTRAL SECURITIES CORP (CET) Transaction Date: May 19, 2026 | Filing ID: 000037

2026-05-08 13:12

New Form 13F-HR - CENTRAL SECURITIES CORP Filed: 2026-05-08 AccNo: 0001209992-26-000035 Size: 17 KB

2026-04-28 20:15

Central Securities Corporation Releases Report to Stockholders

2026-04-28 16:25

New Form N-30B-2 - CENTRAL SECURITIES CORP Filed: 2026-04-28 AccNo: 0001999371-26-009246 Size: 158 KB